Dr. Agarwal's Health Care Limited (BOM:544350)

Market Cap	142.34B +2.6%
Revenue (ttm)	19.76B +23.5%
Net Income	1.26B +40.6%
EPS	3.96 +28.5%
Shares Out	n/a
PE Ratio	112.92
Forward PE	85.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,993
Average Volume	4,281
Open	434.40
Previous Close	441.70
Day's Range	433.20 - 451.20
52-Week Range	327.40 - 567.80
Beta	n/a
RSI	47.52
Earnings Date	May 26, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr...

• Industry: Health Services
• Founded: 2010
• Employees: 4,214
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544350

Financial Performance

In fiscal year 2025, Dr. Agarwal's Health Care's revenue was 17.11 billion, an increase of 28.44% compared to the previous year's 13.32 billion. Earnings were 834.60 million, an increase of 0.48%.